Diagnostic and Therapeutic Considerations for Extramedullary Leukemia Richard BakstAnn PowersJoachim Yahalom Leukemia (A Aguayo, Section Editor) 24 June 2020 Article: 75
Gut Microbiome Modulation Via Fecal Microbiota Transplant to Augment Immunotherapy in Patients with Melanoma or Other Cancers Jennifer L. McQuadeGabriel O. OlogunJennifer A. Wargo Melanoma (RJ Sullivan, Section Editor) 24 June 2020 Article: 74
Transitioning to a New Normal in the Post-COVID Era Di M. JiangAlejandro BerlinSrikala S. Sridhar Invited Commentary 22 June 2020 Article: 73
Cardioprotective Strategies to Prevent Cancer Treatment-Related Cardiovascular Toxicity: a Review Jenica N. Upshaw Cardio-oncology (EH Yang, Section Editor) 20 June 2020 Article: 72
Prehabilitative Exercise for the Enhancement of Physical, Psychosocial, and Biological Outcomes Among Patients Diagnosed with Cancer Kyuwan LeeJudy ZhouChristina M. Dieli-Conwright Cardio-oncology (EH Yang, Section Editor) 15 June 2020 Article: 71
Spectrum and Clinical Activity of PD-1/PD-L1 Inhibitors: Regulatory Approval and Under Development Leandro Jonata Carvalho OliveiraAline Bobato Lara GongoraDenis Leonardo Fontes Jardim Immuno-oncology (RM Bukowski and JH Finke, Section Editors) 12 June 2020 Article: 70
Management of the Small Renal Mass: a 2020 Update Rand N. Wilcox Vanden BergSpyridon P. BasourakosTimothy D. McClure Interventional Oncology (DC Madoff, Section Editor) 09 June 2020 Article: 69
Morcellation of the Uterus: Is There Any Place? Michael J. HalaskaMyriam GraciaIgnacio Zapardiel Gynecologic Cancers (NS Reed, Section Editor) 09 June 2020 Article: 68
Cardiac Biomarkers in Patients with Cancer: Considerations, Clinical Implications, and Future Avenues Valentina BracunJoseph Pierre AboumsallemRudolf A. de Boer Cardio-oncology (EH Yang, Section Editor) Open access 09 June 2020 Article: 67
Proteasome Inhibitor-Related Cardiotoxicity: Mechanisms, Diagnosis, and Management Perry WuOhad OrenEric H. Yang Cardio-oncology (EH Yang, Section Editor) 08 June 2020 Article: 66
New Insights into Mechanisms of Immune Checkpoint Inhibitor-Induced Cardiovascular Toxicity Arjun KhungerLucas BattelNikhil Agrawal Cardio-oncology (EH Yang, Section Editor) 08 June 2020 Article: 65
